EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice-Reference-Cited by-同舟云学术

EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice

Published:2021-10 Issue: Volume:142 Page:112007
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

García-Martín Adela,Navarrete Carmen,Garrido-Rodríguez Martin,Prados María E.,Caprioglio Diego,Appendino Giovanni,Muñoz Eduardo

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference55 articles.

1. The processes and mechanisms of cardiac and pulmonary fibrosis;Murtha;Front Physiol.,2017

2. C. American Heart Association Statistics, S. Stroke Statistics, Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association;Writing Group;Circulation,2016

3. Assessment of nonischemic myocardial fibrosis;Jellis;J. Am. Coll. Cardiol.,2010

4. Myocardial fibrosis predicts ventricular tachyarrhythmias;Disertori;Trends Cardiovasc Med,2017

5. ECM remodeling in hypertensive heart disease;Berk;J. Clin. Investig.,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders;Annals of Plastic Surgery;2024-06

2. Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia;2024-04-29

3. Pharmacological inhibition of the ACE/Ang-2/AT1 axis alleviates mechanical ventilation-induced pulmonary fibrosis;International Immunopharmacology;2024-04

4. Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure;Biomedicine & Pharmacotherapy;2024-04

5. Combination losartan with hyaluronic acid modified diethyldithiocarbamate loaded hollow copper sulfide nanoparticles for the treatment of breast cancer and metastasis;Chinese Chemical Letters;2024-03